ClinicalTrials.Veeva

Menu

Cross-linking of Corneal Collagen (CXL) With Ultraviolet-A in Asymmetric Corneas

C

Cxlusa

Status

Terminated

Conditions

Ectasia
Keratoconus
Degeneration

Treatments

Drug: Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)
Drug: Ciprofloxicin or Vigamox or other.
Drug: Steroid (FML, Pred Forte, Flarex, etc.)

Study type

Observational

Funder types

Industry

Identifiers

NCT01189864
CXL (12 & older)

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy of ultraviolet-A (UVA)-induced cross-linking of corneal collagen (CXL) as a method to increase the biomechanical and biochemical stability of the cornea by inducing additional cross-links within or between collagen fibers using UVA light and the photo- mediator riboflavin. The purpose of this study is to generate data for presentation at medical meetings and for peer-review publication. The data generated by this study will not be submitted to the FDA to support commercialization of these riboflavin drops.

Enrollment

3,493 patients

Sex

All

Ages

12+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 12 years of age or older
  • Diagnosis of keratoconus, FFKC, post-LASIK ectasia, or pellucid marginal degeneration or forme fruste pellucid marginal degeneration (FFPMD).
  • Diagnosis of FFKC
  • History of Radial Keratotomy with fluctuating vision
  • Ability to provide written informed consent
  • Likely to complete all study visits
  • Minimum corneal thickness of at least 300 Measured by ultrasound or Pentacam
  • At least 6 months since last corneal surgery (Intacs/PRK/LASIK/Epi-LASIK/LASEK)

Exclusion criteria

  • Severe corneal scarring that markedly affects vision
  • Contraindications to any study medications or their components
  • Pregnancy or breast feeding
  • Active Herpes Corneal Disease

Trial design

3,493 participants in 3 patient groups

Ciprofloxicin or Vigamox or other.
Treatment:
Drug: Ciprofloxicin or Vigamox or other.
Nonsteroidal (Acular, Voltaren Xibrom, etc)
Treatment:
Drug: Nonsteroidal (Acular, Acuvail, Voltaren Xibrom, etc)
Steroid (FML, Pred Forte, Flarex, etc.)
Treatment:
Drug: Steroid (FML, Pred Forte, Flarex, etc.)

Trial contacts and locations

16

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems